The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Quality of life (QOL) and toxicity among patients in CALGB 80405.
Michelle Joy Naughton
No relevant relationships to disclose
Deborah Schrag
No relevant relationships to disclose
Alan Paul Venook
No relevant relationships to disclose
Donna Niedzwiecki
No relevant relationships to disclose
Roger T. Anderson
Consultant or Advisory Role - Abbott Laboratories; Bayer
Heinz-Josef Lenz
Employment or Leadership Position - Bristol-Myers Squibb; Genentech; Merck
Honoraria - Bristol-Myers Squibb; Genentech; Merck
Research Funding - Bristol-Myers Squibb; Genentech
Stephen S. Grubbs
No relevant relationships to disclose